Trevi Therapeutics, Inc. TRVI
13.65 USD +0.03 (+0.22%)
Regular-session close
13.65 0.00 0.00%
After hours · Nov 13, 4:26 PM ET
13.17 Day range 13.88
9.99 52-week range 19.50
- YTD
- +9.03%
- 1 year
- +19.11%
News
seekingalpha.com Trevi Therapeutics, Inc. (TRVI) Q3 2026 Earnings Call Transcript Trevi Therapeutics, Inc. (TRVI) Q3 2026 Earnings Call Transcript
marketbeat.com What Trevi Therapeutics (TRVI) Said on Its Q3 Earnings Call Trevi Therapeutics NASDAQ: TRVI said it remains on track to report results from its lead chronic cough trials in 2027 and 2028, while preparing a new study in patients with interstitial lung disease…
benzinga.com Trevi Therapeutics Q3 2026 Earnings Call Transcript Trevi Therapeutics (NASDAQ:TRVI) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com Trevi Therapeutics Q3 EPS $(0.13), Inline Trevi Therapeutics (NASDAQ:TRVI) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate. This is a 62.5 percent decrease over losses of $(0.08) per share from the…
globenewswire.com Trevi Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates Initiated Phase 3 OCEAN-2 trial for patients with IPF-related chronic cough in the third quarter; both Phase 3 OCEAN trials actively recruiting Positive meeting with the FDA on the non-IPF…benzinga.com Trevi Therapeutics Announces Results From Phase 2b CORAL Trial Accepted As Oral Presentation At CHEST 2026 Annual Meeting Of American College Of Chest Physicians Trevi Therapeutics, Inc. (NASDAQ:TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy oral nalbuphine ER for the treatment of chronic cough in patients with…
benzinga.com Trevi Therapeutics Q2 2026 Earnings Call Transcript Trevi Therapeutics (NASDAQ:TRVI) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For…benzinga.com Jones Trading Maintains Buy on Trevi Therapeutics, Raises Price Target to $28 Jones Trading analyst Debanjana Chatterjee maintains Trevi Therapeutics (NASDAQ:TRVI) with a Buy and raises the price target from $24 to $28.
benzinga.com Oppenheimer Maintains Outperform on Trevi Therapeutics, Raises Price Target to $25 Oppenheimer analyst Leland Gershell maintains Trevi Therapeutics (NASDAQ:TRVI) with a Outperform and raises the price target from $24 to $25.
benzinga.com Cantor Fitzgerald Maintains Overweight on Trevi Therapeutics, Raises Price Target to $30 Cantor Fitzgerald analyst Josh Schimmer maintains Trevi Therapeutics (NASDAQ:TRVI) with a Overweight and raises the price target from $25 to $30.
benzinga.com Trevi Therapeutics Q2 EPS $(0.11), Inline Trevi Therapeutics (NASDAQ:TRVI) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 22.22 percent decrease over losses of $(0.09) per share from the…
benzinga.com This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, with positive outlooks and raised price targets.
benzinga.com This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.benzinga.com/analyst-stock-ratings. INSM initiated with $192 PT.benzinga.com BMO Capital Initiates Coverage On Trevi Therapeutics with Outperform Rating, Announces Price Target of $36 BMO Capital analyst Connor Murphy initiates coverage on Trevi Therapeutics (NASDAQ:TRVI) with a Outperform rating and announces Price Target of $36.
benzinga.com B. Riley Securities Maintains Buy on Trevi Therapeutics, Raises Price Target to $31 B. Riley Securities analyst Mayank Mamtani maintains Trevi Therapeutics (NASDAQ:TRVI) with a Buy and raises the price target from $21 to $31.
benzinga.com Global Payments To Rally More Than 28%? Here Are 10 Top Analyst Forecasts For Monday Wall Street analysts change ratings for FITB, TRVI, JAZZ, GPN, EAT, URBN, MNST. See full list on benzinga.com/analyst-stock-ratingsbenzinga.com HC Wainwright & Co. Maintains Buy on Trevi Therapeutics, Raises Price Target to $24 HC Wainwright & Co. analyst Brandon Folkes maintains Trevi Therapeutics (NASDAQ:TRVI) with a Buy and raises the price target from $21 to $24.
benzinga.com ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday US stocks lower, Nasdaq falls 400 pts. ManpowerGroup shares rise after upbeat earnings. Other big gainers: PHOE, SG, TRVI, DCBO, ZNTL, GPRE, SLS, FEIM, TRV, BHVN, KOS, BJRI, MBX.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals (NASDAQ:SHPH)…
benzinga.com Earnings Scheduled For May 5, 2026
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Netflix, Trevi Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session US stock futures rise, Dow up by 250 pts. Netflix shares fall 9.6% after weak forecast & Reed Hastings' departure. Other stocks also dip in pre-market.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Blaize Holdings Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket Blaize Holdings rose 24.3% in pre-market trading on $50M contract with NeoTensr & MOU with Winmate for edge AI deployments. Other gainers & losers.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Nvidia To Rally Around 79%? Here Are 10 Top Analyst Forecasts For Wednesday Top analysts changed outlook on top names. Mizuho, Needham, Rothschild & Co, HC Wainwright & Co, Stifel, BTIG, Goldman Sachs made changes.
benzinga.com Earnings Scheduled For March 17, 2026
benzinga.com Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com Earnings Scheduled For November 13, 2025 benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
benzinga.com This Adient Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com Earnings Scheduled For May 8, 2025
benzinga.com Earnings Scheduled For March 18, 2025
benzinga.com Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
benzinga.com Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Earnings Scheduled For November 9, 2023 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
benzinga.com Earnings Scheduled For August 10, 2023 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
benzinga.com Earnings Scheduled For May 11, 2023 Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its…
benzinga.com Earnings Scheduled For March 16, 2023 Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.
benzinga.com Earnings Scheduled For November 10, 2022 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
benzinga.com Earnings Scheduled For August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
benzinga.com Earnings Scheduled For May 12, 2022 Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
benzinga.com 34 Stocks Moving In Monday's Mid-Day Session Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions.
benzinga.com 53 Biggest Movers From Yesterday Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average…
benzinga.com Earnings Scheduled For March 17, 2022 Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter.
benzinga.com 68 Biggest Movers From Yesterday Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday.
benzinga.com 67 Biggest Movers From Yesterday Gainers
